Call to arrange a consultation
+1 416 777 0888
Search the site
Sandoz Canada Inc. v. Merck Sharp & Dohme LLC et al.
2025
T-3058-25
Pending
Declaration of Non-infringement
Application for a declaration of non‑infringement regarding pembrolizumab.
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team.
.jpeg)
.jpg)
%20(1).jpg)
.jpg)
